Dong-A University Hospital
11 clinical trials · Sponsor
◉ Watch Dong-A University Hospital
| Record | Firm | Date |
|---|---|---|
| Long-term KRd in Relapsed and/or Refractory Multiple Myeloma (NCT05495620) | Dong-A University Hospital | 2022-08-01 |
| FOLFIRINOX for 2nd-line Treatment of BTC (NCT03778593) | Dong-A University Hospital | 2019-03-01 |
Track Dong-A University Hospital automatically
Every clearance here is in the API, with alerts when new ones post.